fda ruling on tirzepatide today says shortage of GLP-1 drug is over Tirzepatide Wins FDA Approval for

Both routes are effective, though subcutaneous injection has become more popular due to ease and comfort

Eating smaller portions more frequently can help keep acid levels stable

Clinical Uses: Nausea & vomiting (postoperative, drug-induced, migraine-associated) Diabetic gastroparesis Gastroesophageal reflux disease (GERD) Facilitation of small-bowel intubation Adverse Effects: Extrapyramidal symptoms (EPS) such as dystonia, tremors Drowsiness, restlessness Long-term use Tardive dyskinesia Contraindicated in Parkinsons disease & bowel obstruction Clinical Tip: Use short-term (12 weeks) when possible

Patients receive clear administration instructions, video demonstrations for proper reconstitution, and ongoing monitoring through regular check-ins and follow-up laboratory testing

It also has the most adults suffering from diabetes after China, according to the International Diabetes Federation